Cargando…
人源化BCMA CAR-T细胞挽救治疗鼠源BCMA CAR-T细胞治疗后再进展的难治多发性骨髓瘤二例
OBJECTIVE: To observe the efficacy and safety of humanized anti-BCMA chimeric antigen receptor modified（BCMA CAR）-T cell therapy after disease progression with their murine BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma （MM）. METHODS: Study participants underwent leuka...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295619/ https://www.ncbi.nlm.nih.gov/pubmed/34384157 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.010 |